Back

Two year prospective follow up of patients treated with dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation: The GLORIA-AF Registry

29 August 2016 (17:45 - 18:00)
Organised by:
Congress Presentation Part of: Registries coronary artery disease, stroke and intervention Antithrombotic agents ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Menno Huisman

Leiden University Medical Center, Leiden (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
SWEDEHEART: Stent thrombosis and all-cause mortality in bivalirudin and heparin treated ST-elevation myocardial infarction patients undergoing primary percutaneous intervention
Doctor P. Grimfjard (Uppsala, SE)
Slides Video
Presentation thumbnail
Feasibility and safety of direct catheter-based thrombectomy in the treatment of acute ischemic stroke. Prospective registry PRAGUE-16.
Professor P. Widimsky (Prague, CZ)
Slides Video
Presentation thumbnail
Quality Indicators for Acute Myocardial Infarction: rate of implementation and relation with 3 year survival. A study using data from the nationwide FAST-MI 2005 and FAST-MI 2010 registries
Professor F. Schiele (Besancon, FR)
Slides Video
Presentation thumbnail
Modulators of the response to CRT in international practice: the ADVANCE CRT registry
Doctor N. Varma (Cleveland, US)
Presentation thumbnail
ELECTRa (European Lead Extraction ConTRolled) Registry: a deeper snapshot on transvenous lead extraction in europe
Doctor M. Bongiorni (San Giuliano Terme, IT)

Access the full session

Session thumbnail
Registries coronary artery disease, stroke and intervention

The Event

Event poster

ESC Congress 2016

29 August 2016 17:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources